A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

Overview of attention for article published in Alzheimer's Research & Therapy, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 93 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 832 followers.

Vikas Shirsath Another 5-HT6 antagonist fails to show efficacy. https://t.co/5DYowSiVMF https://t.co/MdKJXplelj

08 Apr 2018

Reply Repost Favourite

PF-05212377 (SAM-760): Another example of a failed #Alzheimer's disease trial involving a 5-HT6 antagonist. Terminated October 2015, officially announced February 2016, abstract/poster July 2016, published April 2018. https://t.co/LTH5rlWCk0 https://t.co/m

07 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.